CSIMarket Company Name, Ticker, Competitors, else..


Gilead Sciences Inc   (GILD)
Other Ticker:  
 

Gilead Sciences Inc

GILD's Fundamental analysis



Gilead Sciences Inc 's sales fell by -3.61 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 1189

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -12.77 %

Gilead Sciences Inc 's net income grew by 8108.33 % in I. Quarter 2023 year on year, above company average,

• More on GILD's Growth


Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Gilead Sciences Inc PEG ratio is at 0.75 Company is currently trading with Price to Cash flow multiple of 153.47 in trailing twelve-month period.
Company
17.59
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.63.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.


• More on GILD's Valuation
 
 Total Debt (Millions $) 25,239
 Dividend TTM ($) 2.96 $
 Dividend Yield TTM (%) 3.94 %
 Revenue/Employee (TTM) $ 1,877,986
 Net Income/Employee (TTM) $ 384,653
 Receivable Turnover (TTM) 6.21
 Tangible Book Value (Per Share $) -12.47

Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Gilead Sciences Inc PEG ratio is at 0.75 Company is currently trading with Price to Cash flow multiple of 153.47 in trailing twelve-month period.
Company
17.59
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.63.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.

Gilead Sciences Inc Price to Book Ratio is at 4.69 higher than Indusry Avg. of 4.21, and lower than S&P 500 Avg. of 1343.01

• More on GILD's Valuation

•  Market Capitalization (Millions $) 98,219
•  Shares Outstanding (Millions) 1,261
•  Employees 14,400
•  Revenues (TTM) (Millions $) 27,043
•  Net Income (TTM) (Millions $) 5,539
•  Cash Flow (TTM) (Millions $) 640
•  Capital Exp. (TTM) (Millions $) -590
•  Total Debt (Millions $) 25,239
•  Dividend TTM ($) 2.96 $
•  Dividend Yield TTM (%) 3.94 %
•  Revenue/Employee (TTM) $ 1,877,986
•  Net Income/Employee(TTM) $ 384,653
•  Receivable Turnover Ratio (TTM) 6.21
•  Tangible Book Value (Per Share $) -12.47

•  Market Capitalization (Millions $) 98,219
•  Shares Outstanding (Millions) 1,261
•  Employees 14,400
•  Revenues (TTM) (Millions $) 27,043
•  Net Income (TTM) (Millions $) 5,539
•  Cash Flow (TTM) (Millions $) 640
•  Capital Exp. (TTM) (Millions $) -590


    GILD's Profitability Comparisons
Gilead Sciences Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 26.84 % from 30.68 % in IV. Quarter.

Gilead Sciences Inc net profit margin of 15.51 % is currently ranking no. 20 in Biotechnology & Pharmaceuticals industry, ranking no. 61 in Healthcare sector and number 914 in S&P 500.


Profitability by Segment



  Ratio
•   Capital Ratio (MRQ) 1.28
•  Total Debt to Equity (MRQ) 1.21
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.43
•  Inventory Turnover Ratio (TTM) 3.73



Gilead Sciences Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 26.84 % from 30.68 % in IV. Quarter.

Gilead Sciences Inc net profit margin of 15.51 % is currently ranking no. 20 in Biotechnology & Pharmaceuticals industry, ranking no. 61 in Healthcare sector and number 914 in S&P 500.

• More on GILD's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071